Alpha Tau Medical Ltd (DRTS)
2.49
+0.14
(+5.96%)
USD |
NASDAQ |
May 03, 16:00
2.46
-0.03
(-1.20%)
Pre-Market: 20:00
Alpha Tau Medical SG&A Expense (Quarterly): 2.453M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.453M |
September 30, 2023 | 2.252M |
June 30, 2023 | 2.213M |
March 31, 2023 | 2.338M |
December 31, 2022 | 2.605M |
September 30, 2022 | 2.531M |
Date | Value |
---|---|
June 30, 2022 | 2.564M |
March 31, 2022 | 3.546M |
December 31, 2021 | 0.714M |
September 30, 2021 | 0.602M |
June 30, 2021 | 0.481M |
March 31, 2021 | 0.546M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.481M
Minimum
Jun 2021
3.546M
Maximum
Mar 2022
1.904M
Average
2.295M
Median
SG&A Expense (Quarterly) Benchmarks
Taro Pharmaceutical Industries Ltd | 50.41M |
InspireMD Inc | 4.278M |
BiomX Inc | 2.597M |
Pluri Inc | 2.354M |
Holdco Nuvo Group DG Ltd | -- |